Genetic Risk Factors, Biology, Psychosocial Aspects, and Comparison between Male Breast Cancer and Female Breast Cancer

Mojgan Haji Seyed Ebrahim Darkeh; Edward Azavedo

Authors

Mojgan Haji Seyed Ebrahim Darkeh
Edward Azavedo

Keywords:

men at higher risk to reduce symptom duration before diagnosis

Abstract

Abstract not found

Downloads

How to Cite

Genetic Risk Factors, Biology, Psychosocial Aspects, and Comparison between Male Breast Cancer and Female Breast Cancer. (2014). Global Journal of Medical Research, 14(16), 1-13. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

References

Cutuli B (2007) Strategies in treating male breast cancer. 8(2), 193-202.

Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M, Galimberti V, Luini A, Orecchia R, Viale G, Goldhrisch A, Veronesi U (2004) Male breast cancer: a special therapeutic problem. Anything new? (Review). 24(3), 663-70.

Ian Fentiman, Alain Fourquet, Gabriel Hortobagyi (2006) Male breast cancer Lancet. 367(9510), 595-604. https://doi.org/10.1016/s0140-6736(06)68226-3

Jamal S, Mamoon N, Mushtaq S (2006) Carcinoma of the male breast: a study of 141 cases from northern Pakistan. 7(1), 119-121.

A. Yoney, A. Kucuk, M. Unsal (2009) Male breast cancer: A retrospective anal-ysis. 13, 103-7.

Donegan, Redlich men (1996) Breast cancer in men. 76(2), 343-63.

Crichlow, Galt cancer (1990) Male breast cancer. 70(5), 1165-77.

Burga AM, Fadare O, Lininger RA (2006) Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. 449(5), 507-512. https://doi.org/10.1007/s00428-006-0305-3

Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. 14(1), 20-6.

Donegan WL, Redlich PN, Lang PJ, Gall MT (1998) Carcinoma of the breast in males: a multiinstitutional survey Cancer. 83(3), 498-509.

F. Ravandi-Kashani, T. Hayes (1998) Male breast cancer: a review of the literature. 34(9), 1341-7.

Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. 137(8), 678-87.

Palli D, Falchetti M, Masala G, Lupi R, Sera F, Saieva C, D'Amico C, Ceroti M, Rizzolo P, Caligo MA, Zanna I, Ottini L (2007) Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy. 7, 170.

Akbulut S, Arer I, Kocbiyik A, Yağmurdur MC, Karakayalı H, Haberal M (2009) Male breast cancer: thirteen years' experience of a single center. 6, 4.

B. D'avanzo, C. La Vecchia (1995) Risk factors for male breast cancer. 71(6), 1359-1362. https://doi.org/10.1038/bjc.1995.264

Raffetto Volpe CM, Hoover Collure DW, their evaluation, management (1999) unilateral male breast masses: cancer risk and their evaluation and management. 65(3), 250-3.

Olsson H, Andersson H, Johansson O, Moller TR, Kristoffersson U, Wenngren E (1993) Population-based cohort investigations of the risk for malignant tumors in first-degree relatives and wives of men with breast cancer. 71, 1273-1278.

Brinton LA, Richesson DA, Gierach GL (2008) Prospective Evaluation of Risk Factors for Male Breast Cancer. 100(20), 1477-1481. https://doi.org/10.1093/jnci/djn329

K. Johnson, S. Pan, Y. Mao (2002) Risk factors for male breast cancer in Canada. 11(3), 253-263.

Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A (2001) Risk factors for male breast cancer--a case-control study from Scandinavia. 40(4), 467-71.

Lenfant-Pejovic MH, Mlika-Cabanne N, Bouchardy C, Auquier A (1990) Risk factors for male breast cancer: a Franco-Swiss case-control study. 45(4), 661-5.

Satram-Hoang S, Moran EM, Anton-Culver H, Burras RW, Heimann TM, Boggio I, Dykstra-Long GR, Wood PA, Zulka R, Hufnagel G, Bahan KK (2010) A pilot study of male breast cancer in the Veterans Affairs healthcare system. 29(3), 235-44.

Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A (1991) Breast Cancer in Men: Aspects of Familial Aggregation. 83(12), 849-854. https://doi.org/10.1093/jnci/83.12.849

D. Anderson, M. Badzioch (1992) Breast cancer risks in relatives of male breast cancer patients. 84, 1114-1117.

K. Hemminki, P. Vaittinen (1999) Familial cancers in a nationwide family cancer database: age distribution and prevalence. 35(7), 1109-17.

Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BA, Easton DF, Pharoah PD (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. (1), R2.

Ottini L, Masala G, D'Amico C (2003) BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. 63(2), 342-347.

Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A (2010) Male breast cancer. 73(2), 141-55.

Tai YC, Domchek S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. 99, 1811.

Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M, Peterlongo P, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D (2012) Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy. 134(1), 411-8.

Pal Mortimer JE (2010) Male breast cancer: an update in diagnosis, treatment and molecular profiling Maturitas. 65(4), 308-314.

Gómez-Raposo C, Zambrana F, Sereno M, López M, Casado E (2010) Male breast cancer. 36(6), 451-7.

Leonardo Reis, Fernando Dias, Marcos Castro, Ubirajara Ferreira (2011) Male breast cancer Aging Male. 14(2), 99-109. https://doi.org/10.3109/13685538.2010.535048

Couch FJ, Farid LM, Deshano ML, Tavtigian SV, Calzone K (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. 13(1), 123-125. https://doi.org/10.1038/ng0596-123

Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E (1999) High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. 59, 995-998.

Olafsdottir Thorlacius S, Neuhausen Tryggvadottir L, Tavtigian Jonasson JG, Ogmundsdottir Tulinius H (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. 13, 117-119.

L. Friedman, S. Gayther, T. Kurosaki, D. Gordon, B. Noble, G. Casey, B. Ponder, Anton Culver, H. (1997) Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton Culver H: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. 60, 313-319.

E. Mavraki, I. Gray, D. Bishop, N. Spurr (1997) Mavraki E, Gray IC, Bishop DT, Spurr NK: Germline BRCA2 mutations in men with breast cancer. 76(11), 1428-1431. https://doi.org/10.1038/bjc.1997.574

K. Haraldsson, N. Loman, Q. Zhang (1998) BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. 58(7), 1367-1371.

Kwiatkowska E, Teresiak M, Lamperska KM (2001) BRCA2 germline mutations in male breast cancer patients in the Polish population. 17(1), 73. https://doi.org/10.1002/1098-1004(2001)17:1

Díez O, Cortés J, Domènech M, Pericay C, Brunet J, Alonso C, Baiget M (2000) BRCA2 germ-line mutations in Spanish male breast cancer patients. 11(1), 81-4.

Sverdlov RS, Barshack I, Bar RB, Baruch RG, Hirsh-Yehezkel G, Dagan E, Feinmesser M, Figer A, Friedman E (2000) Genetic analyses of male breast cancer in Israel. 4(3), 313-7.

Parveen Shah, Irfan Robbani, Omar Shah (2009) Clinicopathological study of male breast carcinoma: 24 years of experience Ann Saudi Med. 29(4), 288-293. https://doi.org/10.4103/0256-4947.55314

Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. 20(6), 1480-90.

Mika Tirkkonen, Tommi Kainu, Niklas Loman, �skar J�hannsson, H�kan Olsson, R�sa Barkard�ttir, Null- Kallioniemi, �ke Borg (1999) Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer Genes Chromosomes Cancer. 24(1), 56-61. https://doi.org/10.1002/(sici)1098-2264(199901)24:1

Bulman Evans DG, Howard Young K, Wallace Bayliss S (2008) BRCA1/2 mutation analysis in male breast cancer families from North West England. 7(2), 113-117.

Chodick G, Struewing JP, Ron E, Rutter JL, Iscovich J (2008) Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel. 51(2), 141-7.

Nikola Besic, Barabara Cernivc, Jacques de Grève, Katarina Lokar, Mateja Krajc, Srdan Novakovic, Janez Zgajnar, Erik Teugels (2008) BRCA2 Gene Mutations in Slovenian Male Breast Cancer Patients. 12(2), 203-209. https://doi.org/10.1089/gte.2007.0071

Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, Bartlett JM, Gelmon K, Nahleh Z, Bergh J, Cutuli B, Pruneri G, McCaskill- W, Gralow J, Hortobagyi G, Cardoso F (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. 28(12), 2114-22.

William Anderson, Michelle Althuis, Louise Brinton, Susan Devesa (2004) Is Male Breast Cancer Similar or Different than Female Breast Cancer?. 83(1), 77-86. https://doi.org/10.1023/b:brea.0000010701.08825.2d

management cancer (2005) A Review of the Diagnosis and Management of Male Breast Cancer. 10(7), 471-479.

W. Krause (2004) Male breast cancer--an andrological disease: risk factors and diagnosis Andrologia. 36(6), 346-354.

R. Hultborn, C. Hanson, I. Kopf, I. Verbiene, E. Warnhammar, A. Weimarck (1997) Prevalence of Klinefelter's syndrome in male breast cancer patients. 17, 4293-4297.

J. Newman (1997) Breast cancer in men and mammography of the male breast. 69, 9-36.

Wooster (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. 2(2), 132-4.

I. Young, K. Kurian, C. Annink, I. Kunkler, V. Anderson, B. Cohen, M. Hooper, A. Wyllie, C. Steel (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. 81(1), 141-3.

Idelevich E, Mozes M, Ben-Baruch N, Huszar M, Kruglikova A, Katsnelson R, Shani A (2003) Oncogenes in male breast cancer. 26(3), 259-61.

Anelli Anelli A, Rosen Youngson B (1995) Mutations of the p53 gene in male breast cancer. 75(9), 2233-2238.

Falchetti M, Lupi R, Rizzolo P, Ceccarelli K, Zanna I, Calò V, Tommasi S, Masala G, Paradiso A, Gulino A, Giannini G, Russo A, Palli D, Ottini L (2008) BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. 110(1), 161-7.

Marsh Fackenthal JD, Cummings Richardson AL, Robinson Eng C (2001) Male breast cancer in Cowden syndrome patients with germline PTEN mutations. 38, 159-164.

Boyd J, Rhei E, Federici MG, Borgen PI, Watson P, Franklin B (1999) Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome Breast Cancer Res Treat. 53(1), 87-91. https://doi.org/10.1023/a:1006030116357

Rudlowski (2008) Male Breast Cancer Breast Care (Basel). 3(3), 183-189.

Stalsberg H, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF (1993) Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men Cancer Causes Control. 4(2), 143-151.

Ribeiro GG, Swindell R, Harris M, Baerjee S, Cramer A (1996) A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. 141-146.

Jonasson JG, Agnarsson BA, Thorlacius S (1996) Male breast cancer in Iceland Int J Cancer 1996. 65(4), 446-449. https://doi.org/10.1002/(sici)1097-0215(19960208)65:4

M. Gill, N. Kayani, M. Khan, S. Hasan (2000) Breast diseases in males--a morphological review of 150 cases J Pak Med Assoc. 50(6), 177-179.

L. Temmim, Y. Luqmani, M. Jarallah, I. Juma, M. Mathew (2001) Evaluation of prognostic factors in male breast cancer Breast. 10(2), 166-175.

N. Kayani, M. Khan, Y. Bhurgri, S. Gill, M. Nasir, T. Siddiqui (2003) Male breast cancer J Pak Med Assoc. 53(3), 114-116.

Giordano (2004) Breast carcinoma in men: a population-based study Cancer. 101(1), 51-57.

Mathew J, Perkins GH, Stephens T, Middleton LP, Yang WT (2008) Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients. 191(6), 1631-9.

Bourhafour M, Belbaraka R, Souadka A, M'rabti H, Tijami F, Errihani H (2011) Male breast cancer: a report of 127 cases at a Moroccan institution. 4, 219.

Anderson WF, Devesa SS (2005) In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute Cancer. 104(8), 1733-1741.

Hittmair AP, Lininger RA (1998) Ductal carcinoma in situ (DCIS) in the male breast. 83(10), 2139-2149.

Patterson (2006) Outcome of Men Presenting with Clinical Breast Problems: The Role of Mammography and Ultrasound. 12(5), 418-423.

Lanitis (2008) Diagnosis and management of male breast cancer. 32(11), 2471-6.

Joshi (1996) Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. 77(3), 490-8.

Pant, Dutta (2008) Understanding and management of male breast cancer: a critical review. 25(3), 294-8.

S. Chikaraddi, R. Krishnappa, V. Deshmane (2012) Male breast cancer in Indian patients: is it the same? Indian J Cancer. 49(3), 272. https://doi.org/10.4103/0019-509x.104484

Morimoto T, Komaki K, Yamakawa T, Tanaka T, Oomine Y, Konishi Y, Mori T, Monden Y (1990) Cancer of the male breast. 44(3), 180-4.

B. Sandler, C. Carman, R. Perry (1994) Cancer of the male breast Am Surg. 60(11), 816-820.

Stierer M, Rosen H, Weitensfelder W, Hausmaninger H, Teleky B, Jakesz R, Fruhwirth H, Dünser M, Beller S, Haid A (1995) Male breast cancer: Austrian experience. 19(5), 687-92.

Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, Donohue JH (1998) Molecular markers in male breast carcinoma. 83(9), 1947-55.

Vetto J, Jun SY, Paduch D, Eppich H, Shih R (1999) Stages at presentation, prognostic factors, and outcome of breast cancer in males. 177(5), 379. https://doi.org/10.1016/s0002-9610(99)00067-7

Håkan Olsson (2000) Estrogen Receptor Content in Malignant Breast Tumors in Men-a Review. 5(3), 283-287. https://doi.org/10.1023/a:1009546811429

Meijer-van Gelder, Look MP, Bolt-de J, Peters HA, Klijn JG, Foekens JA (2001) Clinical relevance of biologic factors in male breast cancer. 68, 249-260.

André S, Fonseca I, Pinto AE, Cardoso P, Pereira T, Soares J (2001) Male breast cancer--a reappraisal of clinical and biologic indicators of prognosis. 40(4), 472-8.

D. Muir, R. Kanthan, S. Kanthan (2003) Male versus female breast cancers. A population-based comparative immunohistochemical analysis. 127(1), 36-41.

Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De B, Zoubir M, Maingon P, Mignotte H, de CT, Edeline J, Penault-Llorca F, Romestaing P, Delva C, Comet B, Belkacemi Y (2010) Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. 73(3), 246-54.

Nahleh ZA, Srikantiah R, Safa M (2007) Male breast cancer in the Veterans Affairs population: a comparative analysis. 109(8), 1471-1477. https://doi.org/10.1002/cncr.22589

B. Salvadori, R. Saccozzi, A. Manzari, S. Andreola, R. Conti, F. Cusumano, M. Grassi (1994) Prognosis of breast cancer in males: an analysis of 170 cases. (7).

Goss (1999) Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996 Cancer. 85(3), 629-639.

Shalini Vinod, Susan Pendlebury (1999) Carcinoma of the male breast: a review of adjuvant therapy Australas Radiol. 43(1), 69-72. https://doi.org/10.1046/j.1440-1673.1999.00601.x

K. Tran (1999) Localized male breast carcinoma and family history. 86, 821-825.

Cutuli (1995) Male breast cancer: Results of the treatments and prognostic factors in 397 cases. (12).

G. Macdonald, C. Paltiel, I. Olivotto, S. Tyldesley (2005) A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer. 16(9), 1442-1448. https://doi.org/10.1093/annonc/mdi274

Giordano (2005) Adjuvant systemic therapy for male breast carcinoma Cancer. 104(11), 2359-2364.

(1994) Male breast cancer. Report of a series of 50 cases. 33(7), 767. https://doi.org/10.3109/02841869409083946

Iossa Ciatto S, Bonardi R (1990) Male breast carcinoma: review of a multicenter series of 150 cases. 76(6), 555-8.

B. Rai, S. Ghoshal, S. Sharma (2005) Breast cancer in males: a PGIMER experience. 1(1), 31-33.

Seenu Shukla NK, Raina Goel AK, Singh Rath GK, Deo Kriplani AK (1996) Male breast cancer: a retrospective study from a regional cancer center in northern India. 61(2), 143-148.

Ahmed (2012) Ahmed et al. Management and outcomes of male breast cancer in zaria, Nigeria. 2012, 845143.

Liu D, Xie G, Chen M (2014) Clinicopathologic characteristics and survival of male breast cancer. 19(2), 280-7.

Oksüzoğlu Arslan UY, Aksoy Ozdemir N, Gök Alkış N, Gümüş Kaplan MA, Uncu Berk V, Colak Baykara M, Türker Uyetürk U (2012) Outcome of non-metastatic male breast cancer: 118 patients. 29(2), 554-560.

Avisar (2006) Prognostic factors in node-negative male breast cancer. 7(4), 331-5.

Bloom KJ, Govil H, Gattuso P, Reddy V, Francescatti D (2001) Status of HER-2 in male and female breast carcinoma. 82, 389-392.

Rudlowski C, Friedrichs N, Faridi A, Füzesi L, Moll R, Bastert G, Rath W, Büttner R (2004) Her-2/neu gene amplification and protein expression in primary male breast cancer. 84(3), 215-23.

Moore J, Friedman MI, Gansler T (1998) Prognostic Indicators in Male Breast Carcinoma. 4(4), 261-269. https://doi.org/10.1046/j.1524-4741.1998.440261.x

L. France, S. Michie, P. Barrett-Lee, K. Brain, P. Harper, J. Gray (2000) Male cancer: a qualitative study of male breast cancer. 9(6), 343-348.

Rachel Iredale, Kate Brain, Buddug Williams, Elizabeth France, Jonathon Gray (2005) Gray, J The experiences of men with breast cancer in the United Kingdom. 42(3), 334-341. https://doi.org/10.1016/j.ejca.2005.09.027

B. Williams, R. Iredale, K. Brain, E. France, P. Barrett-Lee, J. Gray (2003) Williams BG, Iredale R, Brain K, France E, Barrett- Lee P, Gray J Experiences of men with breast cancer: an exploratory focus group study. 89(10), 1834-1836.

Kate Brain, Buddug Williams, Rachel Iredale, Liz France, Jonathon Gray (2006) Psychological Distress in Men With Breast Cancer. 24(1), 95-101. https://doi.org/10.1200/jco.2006.10.064

Edith Pituskin, Beverly Williams, Heather-Jane Au, Kristine Martin-Mcdonald (2007) Martin- McDonald, K Experiences of men with breast cancer: a qualitative study. 4(1), 44-51. https://doi.org/10.1016/j.jmhg.2006.12.002

C. Donovan (2007) Flynn, M What Makes a Man a Man? The lived experience of male breast cancer. 30(6), 464-470.

Zokowski (2003) Social barriers to emotional expression and their relation to distress in male and female breast cancer patients. 8, 271-286.

Robinson JD, Metoyer KP, Bhayani N (2008) Breast Cancer in Men: A Need for Psychological Intervention. 15(2), 134-139.

C. Sime (2012) Men's experiences of having breast cancer: a comparison with women's experiences.

Nahleh Z, Girnius S (2006) Male breast cancer: a gender issue. 3, 428-437.

Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS (2004) Male breast cancer: is the incidence increasing?. 11(8), 751-5.

A. Joseph, K. Mokbel (2004) Male breast cancer Int J Fertil Womens Med. 49(5), 198-199.

Miao (2011) Incidence and outcome of male breast cancer: an international population-based study. 29(33), 4381-6.

Carlo La Vecchia, Fabio Levi, Franca Lucchini (1992) Descriptive epidemiology of male breast cancer in Europe. 51(1), 62-66. https://doi.org/10.1002/ijc.2910510113

Rudan I, Rudan N, Strnad M (1995) Differences between male and female breast cancer. I. Epidemiological features. 49(3), 117-20.

Sasco AJ, Lowenfels AB, Pasker-de P (1993) Review article: epidemiology of male breast cancer. A metaanalysis of published case-control studies and discussion of selected aetiological factors. 53(4), 538-49.

Um Ndom P, Eloundou Bell EM, Hossain NM (2012) A meta-analysis of male breast cancer in Africa. 21(3), 237-41.

K. Czene, J. Bergqvist, P. Hall, J. Bergh (2007) Czene K, Bergqvist J, Hall P, Bergh J.How to treat male breast cancer.

J. World (2008) Contractor KB, Kaur K, Rodrigues GS, Kulkarni DM, Singhal H. Male breast cancer: is the scenario changing. 6, 58.

William Anderson, Ismail Jatoi, Julia Tse, Philip Rosenberg (2010) Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer. 28(2), 232-239. https://doi.org/10.1200/jco.2009.23.8162

Perkins (2003) Breast cancer in men Treatment is based on results extrapolated from trials for women with breast cancer BMJ. 327(7409), 239-240.

M. Koc, P. Polat (2001) Koc & Polat Epidemiology and aetiological factors of male breast cancer: a ten years retrospective study in eastern Turkey. 10(6), 531-534.

M. Perrot, J. Deléaval, J. Robert, A. Spiliopoulos (2000) de Perrot M, Deléaval J, Robert J, Spiliopoulos A.Thirty-year experience of surgery for breast carcinoma in men. 166(12), 929-931.

Borgen PI, Wong GY, Vlamis V, Potter C, Hoffmann B, Kinne DW, Osborne MP, McKinnon WM (1992) Current management of male breast cancer. A review of 104 cases. 215(5), 451.

Davis SL, Barse F, Meoli FG (1992) Male breast carcinoma: clinical experience in a suburban community. 92(8), 1005-6.

Boulos Tawil AN, Otrock Chakhachiro ZI, Kandaharian L, Abi El Saghir NS (2012) Clinicopathologic and immunohistochemical characteristics of male breast cancer: a single center experience. 18(1), 65-8.

A. Salehi, H. Zeraati, K. Mohammad, M. Mahmoudi, A. Talei, A. Ghaderi, M. Imanieh, A. Fotouhi (2011) Survival of male breast cancer in fars, South of Iran. 13(2), 99-105.

Seho Park, Joo-Hee Kim, Jaseung Koo, Byeong-Woo Park, Kyong Lee (2008) Clinicopathological characteristics of male breast cancer Yonsei Med J. 49(6), 978. https://doi.org/10.3349/ymj.2008.49.6.978

Akiko Ioka, Hideaki Tsukuma, Wakiko Ajiki, Akira Oshima (2006) Survival of male breast cancer patients: a population-based study in Osaka, Japan Jpn J Clin Oncol. 36(11), 699-703. https://doi.org/10.1093/jjco/hyl095

Callari M, Cappelletti V, De L, Musella V, Miodini P, Veneroni S, Gariboldi M, Pierotti MA, Daidone MG (2011) Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. 127(3), 601-10.

M. de Jong, I. Nolte, G. te Meerman, W. van der Graaf, J. Oosterwijk, J. Kleibeuker, M. Schaapveld, E. de Vries (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. 39(4), 225-42.

Wolpert N, Warner E, Seminsky MF, Futreal A, Narod SA (2000) Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada. 1(1), 57-65.

Siddhartha Deb, Nicholas Jene, Kconfab Investigators, Stephen Fox (2012) Deb S, Jene N; Kconf ab Investigators, Fox SB. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas. 12(1), 510. https://doi.org/10.1186/1471-2407-12-510

Laura Ottini, Piera Rizzolo, Ines Zanna, Mario Falchetti, Giovanna Masala, Ketty Ceccarelli, Vania Vezzosi, Alberto Gulino, Giuseppe Giannini, Simonetta Bianchi, Francesco Sera, Domenico Palli (2009) BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. 116(3), 577-586. https://doi.org/10.1007/s10549-008-0194-z

Struewing JP, Coriaty ZM, Ron E (1999) Founder BRCA1/2 Mutations among Male Patients with Breast Cancer in Israel. 65(6), 1800-1802. https://doi.org/10.1086/302678

Syrjäkoski K, Kuukasjarvi T, Waltering K (2004) BRCA2 mutations in 154 Finnish male breast cancer patients Neoplasia 2004. 6(5), 541-545. https://doi.org/10.1593/neo.04193

Kwiatkowska E, Teresiak M, Breborowicz D (2002) Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer. 98(6), 943-945. https://doi.org/10.1002/ijc.10289

Evans DG, Bulman M, Young K (2001) High detection rate for BRCA2 mutations in male breast cancer families from North West England. 1(3-4), 131-133. https://doi.org/10.1023/a:1021165031643

Paillerets Tournier I, Stoppa-Lyonnet Sobol H, Barrois Lidereau R, Coulet Mazoyer S, Chompret Hardouin A, Chappuis Lortholary A, Bonadona Bourdon V, Gilbert Maugard C, Frébourg Nogues C (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. 64(22), 8143-7.

Bevier M, Sundquist K, Hemminki K (2012) Risk of breast cancer in families of multiple affected women and men. 132(2), 723-8.

J. Hecht, D. Winchester (1994) Hecht JR & Winchester DJ Male breast cancer. (4 Suppl 1), 25-30.

Tahmasebi S, Akrami M, Omidvari S (2010) Male Breast Cancer; Analysis of 58 Cases in Shiraz, South of Iran. 31(1), 29-32. https://doi.org/10.3233/bd-2009-0293

Puay Tan, Ivy Sng (1997) Male breast cancer: a retrospective study with immunohistochemical analysis of hormone receptor expression. 29(1), 2-6. https://doi.org/10.1080/00313029700169444

H. Amir, K. Hirji (1992) Carcinoma of the male breast in Tanzania. 84(4), 337-340.

S. André, J. Soares (1990) Morphology of male breast carcinoma in the evaluation of prognosis Pathol Res Pract. 186(6), 745-750.

Chung HC, Kim DL, Koh EH (1991) Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer. 32(2), 126. https://doi.org/10.3349/ymj.1991.32.2.126

Rogers Fox SB, Day CA, Underwood receptor (1992) Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma. 166(1), 13-18.

P. Dawson, T. Paine, S. Wolman (1992) Immunocytochemical characterization of male breast cancer Mod Pathol. 5(6), 621-625.

Borgen PI, Senie RT, McKinnon WM (1997) Carcinoma of the male breast: Analysis of prognosis compared with matched female patients. 4(5), 385-388. https://doi.org/10.1007/bf02305550

M. Sharif, N. Mamoon, Arif (2009) Histological and immuno-histochemical study of male breast carcinoma in Northern Pakistan. 59(2), 67-71.

Manal El-Habbash, Abukris Alwindi (2009) Male breast cancer in Tripoli, Libya. 30(8), 1060-1062. https://doi.org/10.15537/1658-3175.4802

Liukkonen S, Saarto T, Maenpaa H (2010) Male breast cancer: A survey at the Helsinki University Central Hospital during. 49(3), 322-327.

Wick (1999) Low-stage carcinoma of the male breast A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma Am J Clin Pathol. 111(1), 59-69. https://doi.org/10.1093/ajcp/111.1.59

Willsher PC, Leach IH, Ellis IO, Bourke JB, Blamey RW, Robertson JF (1997) A comparison outcome of male breast cancer with female breast cancer. 173, 185-188.

Thomas DB, Jimenez LM, McTiernan A, Rosenblatt K, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF (1992) Breast cancer in men: risk factors with hormonal implications Am J Epidemiol. 135(7), 734-748. https://doi.org/10.1093/oxfordjournals.aje.a116360

Nikolay Dimitrov, Philomena Colucci, Sunil Nagpal (2007) Some aspects of the endocrine profile and management of hormonedependent male breast cancer Oncologist. 12(7), 798-807. https://doi.org/10.1634/theoncologist.12-7-798

A. Agrawal, A. Ayantunde, R. Rampaul, J. Robertson (2007) Male breast cancer: a review of clinical management. 103(1), 11-21.

A. Meguerditchian, M. Falardeau, G. Martin (2002) Male breast carcinoma Can J Surg. 45(4), 296-302.

R. Cooper, B. Gunter, L. Ramamurthy (1994) Mammography in men Radiology. 191(3), 651-656.

McLachlan SA, Erlichman C, Liu FF (1996) Male breast cancer: An 11 year review of 66 patients. 40(3), 225-230. https://doi.org/10.1007/bf01806810

Zujewski Harlan LC, Goodman MT, treatment, survival (2010) Breast cancer in men in the United States. 116(15), 3558-3568.

Schaub NP, Maloney N, Schneider H, Feliberti E, Perry R (2008) Changes in Male Breast Cancer Over a 30- Period. (6), 707-712.

Lina Chen, Prem Chantra, Linda Larsen, Premsri Barton, Montanan Rohitopakarn, Elise Zhu, Lawrence Bassett (2006) Imaging characteristics of malignant lesions of the male breast Radiographics. 26(4), 993-1006. https://doi.org/10.1148/rg.264055116

Holmqvist Nilsson C, Hedenfalk Bergkvist L, Lambe M, Fjällskog ML.Similarities, differences characteristics (2011) Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden). 50(7), 1083-8.

Wang J, Kollias J, Marsh C, Maddern G (2009) Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand? Breast. 18(6), 378-381.

Scott-Conner CE, Jochimsen PR, Menck HR (1999) An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. 126(4), 775-780.

Levi F, Randimbison L, La C (1992) Breast cancer survival in relation to sex and age Oncology. 49(6), 413-417.

Frédéric Marchal, Magalie Salou, Christian Marchal, Anne Lesur, Emmanuel Desandes (2009) Men With Breast Cancer Have Same Disease-Specific and Event-Free Survival as Women. 16(4), 972-978. https://doi.org/10.1245/s10434-009-0327-6

Mitsuyama Anan K, Abe Nishihara K, Ihara Iwashita T, Ono Tamae K (2004) Breast cancer in Japanese men: Does sex affect prognosis?. 11, 180-186.

Herman (2000) Male breast cancer. Does the prognosis differ compared to female?. 47, 191-195.

Foerster R, Foerster FG, Wulff V, Schubotz B, Baaske D, Wolfgarten M, Kuhn WC, Rudlowski C (2011) Matched-pair analysis of patients with female and male breast cancer: a comparative analysis. 11, 335.

Zhou Xia LP, Wang Guo GF, Yuan Wang X (2010) Chinese female breast cancer patients show a better overall survival than their male counterparts. 123(17), 2347-52.

Lukman Thalib, Per Hall (2009) Survival of male breast cancer patients: Population‐based cohort study. 100(2), 292-295. https://doi.org/10.1111/j.1349-7006.2008.01032.x

Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ (2005) Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. 15(10), 773-80.

X. Chen, X. Liu, L. Zhang, S. Li, Y. Shi, Z. Tong (2013) Poorer Survival of Male Breast Cancer Compared with Female Breast Cancer Patients May Be Due to Biological Differences. 43(10), 954-963. https://doi.org/10.1093/jjco/hyt116

L. Baojiang, Liu Tingting, L. Gang, Zhang Li (2012) Male breast cancer: A retrospective study comparing survival with female breast cancer. 4(4), 642-646. https://doi.org/10.3892/ol.2012.809

Gani Müller AC, Eckert Rehm HM, Hehr Bamberg M, treatment?! (2012) Are there biologic differences between male and female breast cancer explaining inferior outcome of men despite equal stage and treatment?!. 188(9), 782-7.

Deshpande Gnerlich JL, Seelam Jeffe DB, Kimbuende E (2011) Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. 18(7), 1837-44.

Debmalya Barh (2009) Biomarkers, critical disease pathways, drug targets, and alternative medicine in male breast cancer Curr Drug Targets. 10(1), 1-8. https://doi.org/10.2174/138945009787122842

P. Sperlongano, D. Pisaniello (2000) Current management of male breast cancer. 71(2), 165-166.